LLY
765.29
-0.98%↓
JNJ
176.29
-0.52%↓
ABBV
221.49
+0.96%↑
UNH
344.26
+1.28%↑
AZN
76.43
-1.87%↓
LLY
765.29
-0.98%↓
JNJ
176.29
-0.52%↓
ABBV
221.49
+0.96%↑
UNH
344.26
+1.28%↑
AZN
76.43
-1.87%↓
LLY
765.29
-0.98%↓
JNJ
176.29
-0.52%↓
ABBV
221.49
+0.96%↑
UNH
344.26
+1.28%↑
AZN
76.43
-1.87%↓
LLY
765.29
-0.98%↓
JNJ
176.29
-0.52%↓
ABBV
221.49
+0.96%↑
UNH
344.26
+1.28%↑
AZN
76.43
-1.87%↓
LLY
765.29
-0.98%↓
JNJ
176.29
-0.52%↓
ABBV
221.49
+0.96%↑
UNH
344.26
+1.28%↑
AZN
76.43
-1.87%↓
24u
Huidig
Min
3.35
Max
3.5
Aanbevelingen | Buy |
---|---|
12 Maanden Prognose | +322.74% upside |
Volgende Winsten | 12 nov 2025 |
---|
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
10 mrt 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Lezen
10 mrt 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Lezen
10 mrt 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Lezen
10 mrt 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Lezen
10 mrt 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Lezen
10 mrt 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lezen
10 mrt 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lezen
Prijswijziging
By TipRanks
12 Maanden Prognose
Gemiddelde 14.5 USD 322.74%
Hoogste 17 USD
Laagste 12 USD
Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Fortress Biotech Inc - Dist. in de afgelopen 3 maanden.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Fortress Biotech Inc - Dist in de afgelopen 3 maanden.
$